Nasdaq is clearly better in every possible way than being on the otc. In that aspect the deal is a positive obviously.
This deal is def great in the long run for new shareholders or ones that haven’t been here long. Or just people jumping in getting 2 for 1 basically for the enzc shares they buy from now until the dividend.
The issue is that it’s still basically a reverse split to get from the otc to nasdaq and anyone well versed in the stock market has to admit that’s a fact. They needed funding for trials, they needed off the otc and this was the only way Charles likely found that it could be done. It’s a clever equivalent of a reverse split and it’ll benefit the company and new shareholders.
It’s those of us original longs that got in with massive amount of shares early in 2020 that are getting screwed here. The reasons have already been explained.
News 
Market Data 
Discover 
AI
